Mar 15-16: Visit us at Clinical Trial Supply, Barcelona

Glemser is a proud session sponsor of Arena’s upcoming Clinical Trial Supply (CTS) Europe conference. The conference will focus on incorporating new technologies to meet the demands of more complex, international clinical trial supply chains, and overcoming persistent clinical supply challenges.

While in attendance, Glemser will introduce ComplianceAuthor™ for Clinical Labeling—our automated solution for end-to-end regulated content management. ComplianceAuthor™ is a quality critical system for Clinical Trial Supply labeling that:

  • Reduces label creation time from 4 weeks to 4 days
  • Replaces error-prone processes and manual interpretation
  • Enhances operational compliance and data integrity
  • Ensures confidence in demonstrating control during audits

The conference is specifically targeted to those with responsibility for clinical supply, logistics, quality assurance, manufacturing and distribution in pharmaceutical, biotech and medical device companies.

If you plan to attend CTS, be sure to visit us at Booth #57 to see a live demo of ComplianceAuthor™. We also encourage you to attend our presentation entitled “Avoid High Risk, Non-Compliant Content”, presented by Tammy Feichtel to learn more about recent customer success with this solution.

To schedule a consultation at CTS, visit http://glemser.com/lp/complianceauthor-clinical-labeling/

For more information on ComplianceAuthor™ for Clinical Labeling email james.swatz@glemser.com.

Tags: , , ,